Top Markets
Coin of the day
Enveric Biosciences, Inc. Enveric Biosciences, Inc.

Enveric Biosciences, Inc.

ENVB
Rank in Stocks #38575
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse... Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
Share Price
$1.48
Market Cap
$883.58K
Change (1 day)
-1.99%
Change (1 year)
-88.89%
Country
US
Trade Enveric Biosciences, Inc. (ENVB)

Category

Price of ENVB with the market cap of B
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
ENVB
$1.48
Market Capitalization of Enveric Biosciences, Inc.(ENVB)
Market Cap: $883.58K
As of August 2026 Enveric Biosciences, Inc. has a market cap of $883.58K. This makes Enveric Biosciences, Inc. the world's 38575th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Enveric Biosciences, Inc. from 2005 to 2026
ENVB compared with Top 5 Most Popular stocks
Price of ENVB Asset B Mkt. of B Results
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
$9,139,694 $883.58K
$5.457T +617,546,778.95%
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
$7,527,057 $883.58K
$4.494T +508,584,842.40%
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
$6,964,282 $883.58K
$4.158T +470,559,523.42%
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
$6,166,690 $883.58K
$3.682T +416,668,116.05%
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
$4,742,939 $883.58K
$2.832T +320,468,743.96%